Staar Prepares For Visian ICL Launch Following Long-Awaited FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical will target the three million U.S. patients with severe myopia as it rolls out its Visian ICL implantable contact lens after announcing long-awaited PMA approval Dec. 23